AwardedBelgiumGoodsFramework agreement€2,732,957
Leveren van Trastuzumab en Rituximab voor intraveneus gebruik
- Published
- Published 8 August 2024
Overview
Leveren van Trastuzumab en Rituximab voor intraveneus gebruik
Key details
- Country
- Belgium
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,732,957
- Procedure
- Limited
- Contract type
- Framework agreement
- Published
- 8 August 2024
Pharmaceutical productsGeneral anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agentsAntineoplastic and immunomodulating agentsAntineoplastic agents
Award outcome
- Awarded value
- €914,240
- Award date
- 19 May 2025
- Contract period
- 4 November 2024 → 14 October 2028
- BIOSIMILAR COLLABORATIONS IRELAND LIMITED
- Celltrion Healthcare Netherlands B.V.
- Pfizer
- sandoz
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
12 November 2025
Contract Notice
23 August 2024
Contract Notice
8 August 2024
Contracting authority
UZ Leuven
Procuring entityLeuven, Belgium
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.